APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digestive Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digestive Drugs Market Outlook and Growth Opportunities 2026

Report ID 173984610419 December 2025194 pages

Choose your research edition.

Industry ResearchDigestive Drugs Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Digestive Drugs Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Digestive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digestive Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Digestive Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Digestive Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digestive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digestive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digestive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digestive Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digestive Drugs market include Eisai, Teva, Sanofi, Johnson & Johnson, Pfizer, Bayer, Jiangsu Aosaikang Pharma, AstraZeneca and Sumitomo, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digestive Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digestive Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digestive Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digestive Drugs market.

Digestive Drugs Segment by Company

Eisai

Teva

Sanofi

Johnson & Johnson

Pfizer

Bayer

Jiangsu Aosaikang Pharma

AstraZeneca

Sumitomo

Kyowa Kirin Pharmaceuticals

Hanmi Pharm

Cadila Pharmaceuticals

Digestive Drugs Segment by Type

OTC

Rx

Digestive Drugs Segment by Application

Hospital

Clinic

Digestive Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Digestive Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digestive Drugs key companies, revenue, market share, and recent developments.

3. To split the Digestive Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digestive Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digestive Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Digestive Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digestive Drugs industry.

Chapter 3: Detailed analysis of Digestive Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digestive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digestive Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digestive Drugs Industry Trends Table 2. Digestive Drugs Industry Drivers Table 3. Digestive Drugs Industry Opportunities and Challenges Table 4. Digestive Drugs Industry Restraints Table 5. Global Digestive Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digestive Drugs Revenue Share by Company (2021-2026) Table 7. Global Digestive Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digestive Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Digestive Drugs Company, Product Type & Application Table 10. Global Digestive Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digestive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of OTC Table 15. Significant Companies of Rx Table 16. Global Digestive Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digestive Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digestive Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digestive Drugs Sales Value Share by Type (2021-2026) Table 20. Global Digestive Drugs Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Global Digestive Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Digestive Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Digestive Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Digestive Drugs Sales Value Share by Application (2021-2026) Table 27. Global Digestive Drugs Sales Value Share by Application (2027-2032) Table 28. Global Digestive Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Digestive Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Digestive Drugs Sales Value Share by Region (2021-2026) Table 31. Global Digestive Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Digestive Drugs Sales Value Share by Region (2027-2032) Table 33. Global Digestive Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Digestive Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Digestive Drugs Sales Value Market Share by Country (2021-2026) Table 36. Global Digestive Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Digestive Drugs Sales Value Market Share by Country (2027-2032) Table 38. Eisai Company Information Table 39. Eisai Business Overview Table 40. Eisai Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Eisai Digestive Drugs Product Portfolio Table 42. Eisai Recent Development Table 43. Teva Company Information Table 44. Teva Business Overview Table 45. Teva Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Teva Digestive Drugs Product Portfolio Table 47. Teva Recent Development Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Sanofi Digestive Drugs Product Portfolio Table 52. Sanofi Recent Development Table 53. Johnson & Johnson Company Information Table 54. Johnson & Johnson Business Overview Table 55. Johnson & Johnson Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Digestive Drugs Product Portfolio Table 57. Johnson & Johnson Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Pfizer Digestive Drugs Product Portfolio Table 62. Pfizer Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer Digestive Drugs Product Portfolio Table 67. Bayer Recent Development Table 68. Jiangsu Aosaikang Pharma Company Information Table 69. Jiangsu Aosaikang Pharma Business Overview Table 70. Jiangsu Aosaikang Pharma Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Jiangsu Aosaikang Pharma Digestive Drugs Product Portfolio Table 72. Jiangsu Aosaikang Pharma Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AstraZeneca Digestive Drugs Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Sumitomo Company Information Table 79. Sumitomo Business Overview Table 80. Sumitomo Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sumitomo Digestive Drugs Product Portfolio Table 82. Sumitomo Recent Development Table 83. Kyowa Kirin Pharmaceuticals Company Information Table 84. Kyowa Kirin Pharmaceuticals Business Overview Table 85. Kyowa Kirin Pharmaceuticals Digestive Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Kyowa Kirin Pharmaceuticals Digestive Drugs Product Portfolio Table 87. Kyowa Kirin Pharmaceuticals Recent Development Table 88. Hanmi Pharm Company Information Table 89. Hanmi Pharm Business Overview Table 90. Hanmi Pharm Digestive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hanmi Pharm Digestive Drugs Product Portfolio Table 92. Hanmi Pharm Recent Development Table 93. Cadila Pharmaceuticals Company Information Table 94. Cadila Pharmaceuticals Business Overview Table 95. Cadila Pharmaceuticals Digestive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Cadila Pharmaceuticals Digestive Drugs Product Portfolio Table 97. Cadila Pharmaceuticals Recent Development Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Digestive Drugs Product Image Figure 2. Global Digestive Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digestive Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Digestive Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. OTC Image Figure 8. Rx Image Figure 9. Global Digestive Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digestive Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digestive Drugs Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Global Digestive Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Digestive Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Digestive Drugs Sales Value Share by Application (2021-2032) Figure 17. Global Digestive Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Digestive Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Digestive Drugs Sales Value (2021-2032) & (US$ Million) Figure 20. North America Digestive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Digestive Drugs Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Digestive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Digestive Drugs Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Digestive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Digestive Drugs Sales Value (2021-2032) & (US$ Million) Figure 26. South America Digestive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Digestive Drugs Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Digestive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Digestive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Digestive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Digestive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Rx
Applications
  • Hospital
  • Clinic
Companies covered
  • Eisai
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • Bayer
  • Jiangsu Aosaikang Pharma
  • AstraZeneca
  • Sumitomo
  • Kyowa Kirin Pharmaceuticals
  • Hanmi Pharm
  • Cadila Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digestive Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digestive Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digestive Drugs Market Dynamics
  1. 2.1 Digestive Drugs Industry Trends
  2. 2.2 Digestive Drugs Industry Drivers
  3. 2.3 Digestive Drugs Industry Opportunities and Challenges
  4. 2.4 Digestive Drugs Industry Restraints
3 Digestive Drugs Market by Company
  1. 3.1 Global Digestive Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Digestive Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Digestive Drugs Company Ranking (2024-2026)
  4. 3.4 Global Digestive Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Digestive Drugs Company Product Type and Application
  6. 3.6 Global Digestive Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digestive Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digestive Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digestive Drugs Market by Type
  1. 4.1 Digestive Drugs Type Introduction
  2. 4.1.1 OTC
  3. 4.1.2 Rx
  4. 4.2 Global Digestive Drugs Sales Value by Type
  5. 4.2.1 Global Digestive Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digestive Drugs Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digestive Drugs Sales Value Share by Type (2021-2032)
5 Digestive Drugs Market by Application
  1. 5.1 Digestive Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Digestive Drugs Sales Value by Application
  5. 5.2.1 Global Digestive Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Digestive Drugs Sales Value by Application (2021-2032)
  7. 5.2.3 Global Digestive Drugs Sales Value Share by Application (2021-2032)
6 Digestive Drugs Regional Value Analysis
  1. 6.1 Global Digestive Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digestive Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digestive Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digestive Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digestive Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Digestive Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digestive Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Digestive Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digestive Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digestive Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digestive Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Digestive Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digestive Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digestive Drugs Sales Value Share by Country, 2025 VS 2032
7 Digestive Drugs Country-level Value Analysis
  1. 7.1 Global Digestive Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digestive Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digestive Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digestive Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digestive Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digestive Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digestive Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digestive Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digestive Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digestive Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digestive Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digestive Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digestive Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digestive Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digestive Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digestive Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digestive Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digestive Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digestive Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digestive Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digestive Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digestive Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digestive Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digestive Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digestive Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digestive Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digestive Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digestive Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digestive Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digestive Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digestive Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digestive Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digestive Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digestive Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digestive Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Digestive Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Digestive Drugs Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Digestive Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Digestive Drugs Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Digestive Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Digestive Drugs Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Digestive Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Digestive Drugs Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Digestive Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Digestive Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Digestive Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Digestive Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Jiangsu Aosaikang Pharma
  38. 8.7.1 Jiangsu Aosaikang Pharma Company Information
  39. 8.7.2 Jiangsu Aosaikang Pharma Business Overview
  40. 8.7.3 Jiangsu Aosaikang Pharma Digestive Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Aosaikang Pharma Digestive Drugs Product Portfolio
  42. 8.7.5 Jiangsu Aosaikang Pharma Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Digestive Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Digestive Drugs Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Sumitomo
  50. 8.9.1 Sumitomo Company Information
  51. 8.9.2 Sumitomo Business Overview
  52. 8.9.3 Sumitomo Digestive Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sumitomo Digestive Drugs Product Portfolio
  54. 8.9.5 Sumitomo Recent Developments
  55. 8.10 Kyowa Kirin Pharmaceuticals
  56. 8.10.1 Kyowa Kirin Pharmaceuticals Company Information
  57. 8.10.2 Kyowa Kirin Pharmaceuticals Business Overview
  58. 8.10.3 Kyowa Kirin Pharmaceuticals Digestive Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kyowa Kirin Pharmaceuticals Digestive Drugs Product Portfolio
  60. 8.10.5 Kyowa Kirin Pharmaceuticals Recent Developments
  61. 8.11 Hanmi Pharm
  62. 8.11.1 Hanmi Pharm Company Information
  63. 8.11.2 Hanmi Pharm Business Overview
  64. 8.11.3 Hanmi Pharm Digestive Drugs Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hanmi Pharm Digestive Drugs Product Portfolio
  66. 8.11.5 Hanmi Pharm Recent Developments
  67. 8.12 Cadila Pharmaceuticals
  68. 8.12.1 Cadila Pharmaceuticals Company Information
  69. 8.12.2 Cadila Pharmaceuticals Business Overview
  70. 8.12.3 Cadila Pharmaceuticals Digestive Drugs Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cadila Pharmaceuticals Digestive Drugs Product Portfolio
  72. 8.12.5 Cadila Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst